Sofinnova Investments, Inc. Rhythm Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$13.16 - $22.9 $280,558 - $488,205	-21,319 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $416,360 - $543,634	21,319 New	21,319 $489,000
Q4 2018 Feb 14, 2019	SELL	$24.11 - $31.34 $3.84 Million - $4.99 Million	-159,302 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$26.99 - $35.85 $512,863 - $681,221	19,002 Added 13.54%	159,302 $4.65 Million
Q2 2018 Nov 15, 2018	BUY	$17.02 - $35.2 $2.14 Million - $4.43 Million	125,848 Added 870.8%	140,300 $4.39 Million
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $245,973 - $508,710	14,452 New	14,452 $452,000

178

69.1M

467K

224K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.